Characterization of Gene Expression Profiles in Alzheimer's Disease and Osteoarthritis: A Bioinformatics Study

Overview

Journal PLoS One

Date 2025 Feb 7

PMID 39919076

Authors

Nian Liu

Qian Deng

Zining Peng

Danning Mao

Yuanbo Huang

Fanyu Meng

Xiaoyu Zhang

Jiayan Shen

Zhaofu Li

Weitian Yan

Jiangyun Peng

Affiliations

Soon will be listed here.

Abstract

Background: Alzheimer's disease (AD) and Osteoarthritis (OA) have been shown to have a close association in previous studies, but the pathogenesis of both diseases are unclear. This study explores the potential common molecular mechanisms between AD and OA through bioinformatics analysis, providing new insights for clinical treatment strategies.

Methods: The AD and OA-related datasets were downloaded from the gene expression database GEO. The datasets were analyzed to obtain differentially expressed gene (DEG) datasets for OA and AD, respectively. The intersection of these DEGs was analyzed to identify common DEGs (Co-DEGs). Subsequently, the Co-DEGs were enriched, and a protein-protein interaction network was constructed to identify core genes. The expression of these genes was validated in a separate dataset, and their diagnostic value for the diseases was analyzed. In addition, the core genes were analyzed using gene set enrichment analysis and single-gene genome variation analysis.

Results: Analysis of DEGs on gene chips from OA and AD patients revealed significant changes in gene expression patterns. Notably, EFEMP2 and TSPO, genes associated with inflammatory responses, showed lower expression levels in both AD and OA patients, suggesting a downregulation in the pathological backgrounds of these diseases. Additionally, GABARAPL1, which is crucial for the maturation of autophagosomes, was found to be upregulated in both conditions. These findings suggest the potential of these genes as diagnostic biomarkers and potential therapeutic targets. However, to confirm the effectiveness of these genes as therapeutic targets, more in-depth mechanistic studies are needed in the future, particularly to explore the feasibility and specific mechanisms of combating disease progression by regulating the expression of these genes.

Conclusions: This study suggests that AD and OA shares common molecular mechanisms. The identification of EFEMP2, GABARAPL1, and TSPO as key target genes highlights potential common factors in both diseases. Further investigation into these findings could lead to new candidate targets and treatment directions for AD and OA, offering promising avenues for developing more effective and targeted therapeutic interventions.

References

Chen X, Wang J, Song L, Yu Y, Shi M, Jiang W . Downregulation of fibulin-4 inhibits autophagy and promotes the sensitivity of esophageal squamous cell carcinoma cells to apatinib by activating the Akt-mTOR signaling pathway. Thorac Cancer. 2022; 13(18):2592-2605. PMC: 9475232. DOI: 10.1111/1759-7714.14595. View

Hansen S, Wang H . The shared role of cholesterol in neuronal and peripheral inflammation. Pharmacol Ther. 2023; 249:108486. DOI: 10.1016/j.pharmthera.2023.108486. View

Horie K, Salvado G, Barthelemy N, Janelidze S, Li Y, He Y . CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer's disease. Nat Med. 2023; 29(8):1954-1963. PMC: 10427417. DOI: 10.1038/s41591-023-02443-z. View

Cheng X, Wei Y, Qian Z, Han L . Autophagy Balances Neuroinflammation in Alzheimer's Disease. Cell Mol Neurobiol. 2022; 43(4):1537-1549. PMC: 11412430. DOI: 10.1007/s10571-022-01269-6. View

van der Kant R, Langness V, Herrera C, Williams D, Fong L, Leestemaker Y . Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-β in iPSC-Derived Alzheimer's Disease Neurons. Cell Stem Cell. 2019; 24(3):363-375.e9. PMC: 6414424. DOI: 10.1016/j.stem.2018.12.013. View

Choi W, Lee G, Song W, Koh J, Yang J, Kwak J . The CH25H-CYP7B1-RORα axis of cholesterol metabolism regulates osteoarthritis. Nature. 2019; 566(7743):254-258. DOI: 10.1038/s41586-019-0920-1. View

Kostev K, Hadji P, Jacob L . Impact of Osteoporosis on the Risk of Dementia in Almost 60,000 Patients Followed in General Practices in Germany. J Alzheimers Dis. 2018; 65(2):401-407. DOI: 10.3233/JAD-180569. View

Pradhan A, Neumuller T, Klug C, Fuchs S, Schlegel M, Ballmann M . Chronic administration of XBD173 ameliorates cognitive deficits and neuropathology via 18 kDa translocator protein (TSPO) in a mouse model of Alzheimer's disease. Transl Psychiatry. 2023; 13(1):332. PMC: 10611770. DOI: 10.1038/s41398-023-02630-z. View

Chen J, Zhao H, Liu M, Chen L . A new perspective on the autophagic and non-autophagic functions of the GABARAP protein family: a potential therapeutic target for human diseases. Mol Cell Biochem. 2023; 479(6):1415-1441. DOI: 10.1007/s11010-023-04800-5. View

10.

Grigg I, Ivashko-Pachima Y, Hait T, Korenkova V, Touloumi O, Lagoudaki R . Tauopathy in the young autistic brain: novel biomarker and therapeutic target. Transl Psychiatry. 2020; 10(1):228. PMC: 7359319. DOI: 10.1038/s41398-020-00904-4. View

11.

DAdamo S, Alvarez-Garcia O, Muramatsu Y, Flamigni F, Lotz M . MicroRNA-155 suppresses autophagy in chondrocytes by modulating expression of autophagy proteins. Osteoarthritis Cartilage. 2016; 24(6):1082-91. PMC: 4875787. DOI: 10.1016/j.joca.2016.01.005. View

12.

Zhang L, Liu N, Shao J, Gao D, Liu Y, Zhao Y . Bidirectional control of parathyroid hormone and bone mass by subfornical organ. Neuron. 2023; 111(12):1914-1932.e6. DOI: 10.1016/j.neuron.2023.03.030. View

13.

Wang J, Zhang Y, Cao J, Wang Y, Anwar N, Zhang Z . The role of autophagy in bone metabolism and clinical significance. Autophagy. 2023; 19(9):2409-2427. PMC: 10392742. DOI: 10.1080/15548627.2023.2186112. View

14.

Shen Y, Zhou T, Liu X, Liu Y, Li Y, Zeng D . Sevoflurane-Induced miR-211-5p Promotes Neuronal Apoptosis by Inhibiting Efemp2. ASN Neuro. 2021; 13:17590914211035036. PMC: 8819752. DOI: 10.1177/17590914211035036. View

15.

Zhang M, Qian X, Hu J, Zhang Y, Lin X, Hai W . Integrating TSPO PET imaging and transcriptomics to unveil the role of neuroinflammation and amyloid-β deposition in Alzheimer's disease. Eur J Nucl Med Mol Imaging. 2023; 51(2):455-467. PMC: 10774172. DOI: 10.1007/s00259-023-06446-3. View

16.

Irwin M, Vitiello M . Implications of sleep disturbance and inflammation for Alzheimer's disease dementia. Lancet Neurol. 2019; 18(3):296-306. DOI: 10.1016/S1474-4422(18)30450-2. View

17.

Loskutova N, Watts A, Burns J . The cause-effect relationship between bone loss and Alzheimer's disease using statistical modeling. Med Hypotheses. 2018; 122:92-97. PMC: 6318806. DOI: 10.1016/j.mehy.2018.10.024. View

18.

Park S, Shin B . Intermittent fasting with a high-protein diet mitigated osteoarthritis symptoms by increasing lean body mass and reducing inflammation in osteoarthritic rats with Alzheimer's disease-like dementia. Br J Nutr. 2021; 127(1):55-67. DOI: 10.1017/S0007114521000829. View

19.

Liu H, Luo J . miR-211-5p contributes to chondrocyte differentiation by suppressing Fibulin-4 expression to play a role in osteoarthritis. J Biochem. 2019; 166(6):495-502. DOI: 10.1093/jb/mvz065. View

20.

Li M, Jia J, Zhang X, Dai H . Selective binding of mitophagy receptor protein Bcl-rambo to LC3/GABARAP family proteins. Biochem Biophys Res Commun. 2020; 530(1):292-300. DOI: 10.1016/j.bbrc.2020.07.039. View